NeoStem, Inc. Highlights Business Model to Capitalize on Projected $8.5 Billion Market for Stem Cell-Based Therapeutics in New Investor Fact Sheet

NEW YORK--(BUSINESS WIRE)--NeoStem, Inc. (OTCBB:NEOI), the first company to specialize in the collection, processing and storage of stem cells from healthy adult donors for personal use in times of critical medical need, invites investors to review a new Investor Fact Sheet that outlines the Company’s unique technologies and strategy to capitalize on the growing market for stem cell-related services and potential medical treatments.
MORE ON THIS TOPIC